Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Cash from Investing Activities (2021 - 2025)

Cardio Diagnostics Holdings' Cash from Investing Activities history spans 5 years, with the latest figure at -$257819.0 for Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 228.15% year-over-year to -$257819.0; the TTM value through Sep 2025 reached -$395564.0, up 56.84%, while the annual FY2024 figure was -$404190.0, 49.11% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was -$257819.0 at Cardio Diagnostics Holdings, down from -$35717.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$2512.0 in Q4 2022 and bottomed at -$65.0 million in Q4 2021.
  • The 5-year median for Cash from Investing Activities is -$74254.0 (2024), against an average of -$4.2 million.
  • The largest annual shift saw Cash from Investing Activities surged 100.0% in 2022 before it crashed 22469.59% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$65.0 million in 2021, then soared by 100.0% to -$2512.0 in 2022, then plummeted by 22469.59% to -$566948.0 in 2023, then surged by 90.37% to -$54613.0 in 2024, then crashed by 372.08% to -$257819.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Cash from Investing Activities are -$257819.0 (Q3 2025), -$35717.0 (Q2 2025), and -$47415.0 (Q1 2025).